# A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

Source: https://onco.cc/trials/nct06902389/  
OnCo record `nct06902389` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A trial tests engineered T cells that can target several tumor proteins, including TROP2. Its activity cannot be attributed to TROP2 targeting alone.

## Summary

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma. ClinicalTrials.gov record last updated 2025-09-03: recruiting. Enrollment is planned at 30 participants. Primary completion is estimated at 2028-01-01. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Registry id: NCT06902389
- Phase: 1/2
- Setting: A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma
- Sponsor: Eastern Hepatobiliary Surgery Hospital

## Notes

- ClinicalTrials.gov record last updated 2025-09-03: recruiting. Enrollment is planned at 30 participants. Primary completion is estimated at 2028-01-01. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT06902389: https://clinicaltrials.gov/study/NCT06902389

## Connected records

- targets: [TROP2](https://onco.cc/targets/trop2/)

---
JSON: https://onco.cc/api/v1/entities/nct06902389.json